UniProt ID | 1433E_HUMAN | |
---|---|---|
UniProt AC | P62258 | |
Protein Name | 14-3-3 protein epsilon | |
Gene Name | YWHAE | |
Organism | Homo sapiens (Human). | |
Sequence Length | 255 | |
Subcellular Localization | Nucleus . Cytoplasm . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV. | |
Protein Description | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner (By similarity). Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm. [PubMed: 12917326] | |
Protein Sequence | MDDREDLVYQAKLAEQAERYDEMVESMKKVAGMDVELTVEERNLLSVAYKNVIGARRASWRIISSIEQKEENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAANTGESKVFYYKMKGDYHRYLAEFATGNDRKEAAENSLVAYKAASDIAMTELPPTHPIRLGLALNFSVFYYEILNSPDRACRLAKAAFDDAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDMQGDGEEQNKEALQDVEDENQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDDREDLV -------CCHHHHHH | 12.49 | 19413330 | |
1 | Sulfoxidation | -------MDDREDLV -------CCHHHHHH | 12.49 | 28465586 | |
4 | Methylation | ----MDDREDLVYQA ----CCHHHHHHHHH | 34.76 | - | |
9 | Phosphorylation | DDREDLVYQAKLAEQ CHHHHHHHHHHHHHH | 15.28 | 27155012 | |
12 | Acetylation | EDLVYQAKLAEQAER HHHHHHHHHHHHHHH | 32.48 | 23749302 | |
12 | Ubiquitination | EDLVYQAKLAEQAER HHHHHHHHHHHHHHH | 32.48 | 21890473 | |
12 | Ubiquitination | EDLVYQAKLAEQAER HHHHHHHHHHHHHHH | 32.48 | 21890473 | |
23 | Sulfoxidation | QAERYDEMVESMKKV HHHHHHHHHHHHHHH | 3.56 | 30846556 | |
26 | Phosphorylation | RYDEMVESMKKVAGM HHHHHHHHHHHHCCC | 25.21 | 30622161 | |
27 | Sulfoxidation | YDEMVESMKKVAGMD HHHHHHHHHHHCCCC | 2.85 | 30846556 | |
28 | Succinylation | DEMVESMKKVAGMDV HHHHHHHHHHCCCCE | 54.07 | 23954790 | |
28 | Acetylation | DEMVESMKKVAGMDV HHHHHHHHHHCCCCE | 54.07 | 25953088 | |
28 | Ubiquitination | DEMVESMKKVAGMDV HHHHHHHHHHCCCCE | 54.07 | - | |
29 | Ubiquitination | EMVESMKKVAGMDVE HHHHHHHHHCCCCEE | 28.77 | 21906983 | |
33 | Sulfoxidation | SMKKVAGMDVELTVE HHHHHCCCCEEEEHH | 3.63 | 21406390 | |
38 | Phosphorylation | AGMDVELTVEERNLL CCCCEEEEHHHHHHH | 16.62 | 19060867 | |
46 | Phosphorylation | VEERNLLSVAYKNVI HHHHHHHHHHHHHHH | 14.10 | 19664994 | |
49 | Phosphorylation | RNLLSVAYKNVIGAR HHHHHHHHHHHHHHH | 10.84 | 22617229 | |
50 | Ubiquitination | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | 21890473 | |
50 | Succinylation | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | 23954790 | |
50 | Sumoylation | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | 28112733 | |
50 | 2-Hydroxyisobutyrylation | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | - | |
50 | Ubiquitination | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | 21890473 | |
50 | Acetylation | NLLSVAYKNVIGARR HHHHHHHHHHHHHHH | 34.69 | 19608861 | |
59 | Phosphorylation | VIGARRASWRIISSI HHHHHHHHHHHHHHH | 18.31 | 23882029 | |
64 | Phosphorylation | RASWRIISSIEQKEE HHHHHHHHHHHHHHH | 23.92 | 20068231 | |
65 | Phosphorylation | ASWRIISSIEQKEEN HHHHHHHHHHHHHHC | 21.53 | 20068231 | |
69 | Ubiquitination | IISSIEQKEENKGGE HHHHHHHHHHCCCCH | 54.96 | 6983 | |
69 | Acetylation | IISSIEQKEENKGGE HHHHHHHHHHCCCCH | 54.96 | 19608861 | |
73 | Ubiquitination | IEQKEENKGGEDKLK HHHHHHCCCCHHHHH | 72.13 | 21906983 | |
78 | Acetylation | ENKGGEDKLKMIREY HCCCCHHHHHHHHHH | 45.78 | 23749302 | |
80 | Ubiquitination | KGGEDKLKMIREYRQ CCCHHHHHHHHHHHH | 37.71 | - | |
85 | Phosphorylation | KLKMIREYRQMVETE HHHHHHHHHHHHHHH | 9.04 | 28634298 | |
88 | Sulfoxidation | MIREYRQMVETELKL HHHHHHHHHHHHHHH | 1.86 | 21406390 | |
91 | Phosphorylation | EYRQMVETELKLICC HHHHHHHHHHHHHHH | 34.90 | 20363803 | |
97 | Glutathionylation | ETELKLICCDILDVL HHHHHHHHHHHHHHH | 2.18 | 22555962 | |
97 | S-nitrosylation | ETELKLICCDILDVL HHHHHHHHHHHHHHH | 2.18 | 22178444 | |
97 | S-palmitoylation | ETELKLICCDILDVL HHHHHHHHHHHHHHH | 2.18 | 29575903 | |
97 | S-nitrosocysteine | ETELKLICCDILDVL HHHHHHHHHHHHHHH | 2.18 | - | |
98 | Glutathionylation | TELKLICCDILDVLD HHHHHHHHHHHHHHH | 2.64 | 22555962 | |
98 | S-nitrosylation | TELKLICCDILDVLD HHHHHHHHHHHHHHH | 2.64 | 22178444 | |
98 | S-palmitoylation | TELKLICCDILDVLD HHHHHHHHHHHHHHH | 2.64 | 29575903 | |
98 | S-nitrosocysteine | TELKLICCDILDVLD HHHHHHHHHHHHHHH | 2.64 | - | |
106 | 2-Hydroxyisobutyrylation | DILDVLDKHLIPAAN HHHHHHHHHCCCCCC | 35.83 | - | |
106 | Ubiquitination | DILDVLDKHLIPAAN HHHHHHHHHCCCCCC | 35.83 | 21906983 | |
106 | Ubiquitination | DILDVLDKHLIPAAN HHHHHHHHHCCCCCC | 35.83 | 21890473 | |
106 | Acetylation | DILDVLDKHLIPAAN HHHHHHHHHCCCCCC | 35.83 | 21466224 | |
114 | Phosphorylation | HLIPAANTGESKVFY HCCCCCCCCCCEEEE | 37.28 | 23911959 | |
117 | Phosphorylation | PAANTGESKVFYYKM CCCCCCCCEEEEEEE | 35.15 | 108826409 | |
118 | Ubiquitination | AANTGESKVFYYKMK CCCCCCCEEEEEEEC | 31.87 | 21890473 | |
118 | 2-Hydroxyisobutyrylation | AANTGESKVFYYKMK CCCCCCCEEEEEEEC | 31.87 | - | |
118 | Succinylation | AANTGESKVFYYKMK CCCCCCCEEEEEEEC | 31.87 | 23954790 | |
118 | Acetylation | AANTGESKVFYYKMK CCCCCCCEEEEEEEC | 31.87 | 19608861 | |
118 | Ubiquitination | AANTGESKVFYYKMK CCCCCCCEEEEEEEC | 31.87 | 21890473 | |
122 | Phosphorylation | GESKVFYYKMKGDYH CCCEEEEEEECCCHH | 7.98 | 24719451 | |
123 | Acetylation | ESKVFYYKMKGDYHR CCEEEEEEECCCHHH | 23.82 | 19608861 | |
123 | 2-Hydroxyisobutyrylation | ESKVFYYKMKGDYHR CCEEEEEEECCCHHH | 23.82 | - | |
123 | Ubiquitination | ESKVFYYKMKGDYHR CCEEEEEEECCCHHH | 23.82 | 21890473 | |
123 | Ubiquitination | ESKVFYYKMKGDYHR CCEEEEEEECCCHHH | 23.82 | 21890473 | |
123 | Succinylation | ESKVFYYKMKGDYHR CCEEEEEEECCCHHH | 23.82 | 23954790 | |
125 | Ubiquitination | KVFYYKMKGDYHRYL EEEEEEECCCHHHHH | 44.47 | 21906983 | |
125 | 2-Hydroxyisobutyrylation | KVFYYKMKGDYHRYL EEEEEEECCCHHHHH | 44.47 | - | |
130 | Methylation | KMKGDYHRYLAEFAT EECCCHHHHHHHHHC | 23.18 | - | |
131 | Phosphorylation | MKGDYHRYLAEFATG ECCCHHHHHHHHHCC | 9.28 | 24927040 | |
137 | Phosphorylation | RYLAEFATGNDRKEA HHHHHHHCCCCHHHH | 41.67 | 26437602 | |
142 | Malonylation | FATGNDRKEAAENSL HHCCCCHHHHHHHHH | 55.35 | 26320211 | |
142 | Ubiquitination | FATGNDRKEAAENSL HHCCCCHHHHHHHHH | 55.35 | 21890473 | |
142 | 2-Hydroxyisobutyrylation | FATGNDRKEAAENSL HHCCCCHHHHHHHHH | 55.35 | - | |
142 | Acetylation | FATGNDRKEAAENSL HHCCCCHHHHHHHHH | 55.35 | 23954790 | |
142 | Ubiquitination | FATGNDRKEAAENSL HHCCCCHHHHHHHHH | 55.35 | 21890473 | |
148 | Phosphorylation | RKEAAENSLVAYKAA HHHHHHHHHHHHHHH | 18.74 | 21712546 | |
153 | Acetylation | ENSLVAYKAASDIAM HHHHHHHHHHCHHCC | 27.95 | 25953088 | |
153 | Ubiquitination | ENSLVAYKAASDIAM HHHHHHHHHHCHHCC | 27.95 | 21906983 | |
153 | Methylation | ENSLVAYKAASDIAM HHHHHHHHHHCHHCC | 27.95 | - | |
160 | Sulfoxidation | KAASDIAMTELPPTH HHHCHHCCCCCCCCC | 2.82 | 21406390 | |
181 | Phosphorylation | ALNFSVFYYEILNSP EEEEEHHHHHHHCCH | 9.68 | 30459007 | |
187 | Phosphorylation | FYYEILNSPDRACRL HHHHHHCCHHHHHHH | 25.40 | 22817901 | |
196 | Ubiquitination | DRACRLAKAAFDDAI HHHHHHHHHHHHHHH | 44.85 | 21890473 | |
196 | 2-Hydroxyisobutyrylation | DRACRLAKAAFDDAI HHHHHHHHHHHHHHH | 44.85 | - | |
196 | Ubiquitination | DRACRLAKAAFDDAI HHHHHHHHHHHHHHH | 44.85 | 21890473 | |
196 | Acetylation | DRACRLAKAAFDDAI HHHHHHHHHHHHHHH | 44.85 | 26822725 | |
208 | Phosphorylation | DAIAELDTLSEESYK HHHHHHHCCCHHHCC | 44.82 | 29255136 | |
210 | Phosphorylation | IAELDTLSEESYKDS HHHHHCCCHHHCCCH | 41.22 | 19664994 | |
213 | Phosphorylation | LDTLSEESYKDSTLI HHCCCHHHCCCHHHH | 33.17 | 29255136 | |
214 | Phosphorylation | DTLSEESYKDSTLIM HCCCHHHCCCHHHHH | 23.30 | 28176443 | |
215 | Methylation | TLSEESYKDSTLIMQ CCCHHHCCCHHHHHH | 55.25 | 23644510 | |
217 | Phosphorylation | SEESYKDSTLIMQLL CHHHCCCHHHHHHHH | 22.44 | 22617229 | |
218 | Phosphorylation | EESYKDSTLIMQLLR HHHCCCHHHHHHHHH | 30.36 | 29255136 | |
221 | Sulfoxidation | YKDSTLIMQLLRDNL CCCHHHHHHHHHCCC | 2.30 | 30846556 | |
229 | Phosphorylation | QLLRDNLTLWTSDMQ HHHHCCCEEEECCCC | 26.89 | 21815630 | |
232 | Phosphorylation | RDNLTLWTSDMQGDG HCCCEEEECCCCCCC | 20.26 | 25159151 | |
233 | Phosphorylation | DNLTLWTSDMQGDGE CCCEEEECCCCCCCH | 21.36 | 25159151 | |
235 | Sulfoxidation | LTLWTSDMQGDGEEQ CEEEECCCCCCCHHH | 4.87 | 28465586 | |
244 | Acetylation | GDGEEQNKEALQDVE CCCHHHHHHHHHHCH | 44.02 | 26051181 | |
244 | Ubiquitination | GDGEEQNKEALQDVE CCCHHHHHHHHHHCH | 44.02 | 21906983 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 1433E_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 1433E_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-38 AND SER-210, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 ANDLYS-123, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-38 AND SER-210, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASSSPECTROMETRY. |